Cover image of Diabetes Discourse
(3)
Health & Fitness
Medicine
Science

Diabetes Discourse

Updated 4 days ago

Health & Fitness
Medicine
Science
Read more

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.

Read more

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.

iTunes Ratings

3 Ratings
Average Ratings
1
2
0
0
0

iTunes Ratings

3 Ratings
Average Ratings
1
2
0
0
0
Cover image of Diabetes Discourse

Diabetes Discourse

Updated 4 days ago

Read more

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.

Rank #1: Approaching Patients with Diabetes from a Behavioral Perspective

Podcast cover
Read more
Guest: Amy Ozier, PhD, RD
Host: Steven Edelman, MD

The EADS (Eating and Appraisal Due to Emotions and Stress) questionnaire developed by Dr. Amy Ozier, registered dietitian and certified health education specialist, and assistant professor and facilitator of the Certificate of Graduate Study for Eating Disorders and Obesity at Northern Illinois University, helps healthcare professionals determine how psychological and physical factors modulate how much patients with diabetes eat. Does this tool help to bridge the gap when a psychologist is missing from a multi-disciplinary team?  Dr. Ozier joins host Dr. Steven Edelman to discuss overeating as a contributing factor in a patient's overall health, the impact of hyperglycemia and treatment that helps modulate behavior.

Oct 28 2010

Play

Rank #2: Effective Strategies for the Patient with Poorly Controlled Type 2 Diabetes

Podcast cover
Read more
Host: John J. Russell, MD
Guest: Serena Cardillo, MD

Host Dr. John Russell welcomes Dr. Serena Cardillo, Associate Professor of Medicine in the Division of Endocrinology, Diabetes, & Metabolism at Penn Medicine. Dr. Cardillo guides listeners through the challenges in treating diabetic patients whose blood glucose levels remain poorly controlled.

Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only.

Brought to you by

Aug 24 2015

Play

Rank #3: A New Paradigm for the Treatment of Type 2 Diabetes

Podcast cover
Read more
Guest: Ralph A. DeFronzo, MD
Host: Steven Edelman, MD

Insulin resistance in muscle, liver and ß-cell represent the core pathophysiologic defects in type 2 diabetes. In addition, the ominous octet all play important roles in the development of glucose intolerance in people with type 2 diabetes. How will this new paradigm shift our understanding in the way we treat our type 2 patients? Dr. Ralph DeFronzo, professor of medicine and author of the recent Banting Lecture, “From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus,” discusses new therapies based on the pathophysiology. Join host Dr. Steven Edelman to learn more.

Sep 02 2009

Play

Rank #4: Implications of the ACCORD, ADVANCE and VA Diabetes Trials

Podcast cover
Read more
Guest: Richard Bergenstal, MD
Host: Steven Edelman, MD

The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

Nov 19 2009

Play

Rank #5: Toward a Healthier Journey for the Type 2 Diabetes Patient

Podcast cover
Read more
Host: John J. Russell, MD
Guest: Candis Morello, PharmD, CDE

Host Dr. John Russell welcomes Candis M. Morello, PharmD., CDE, FCSHP, Professor of Clinical Pharmacy and Associate Dean for Student Affairs at the Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Morello explains the importance of patient education, communication, and motivation needed to instill a positive and healthy approach to diabetes care.

Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only.

Brought to you by

Aug 17 2015

Play

Rank #6: Where Do SGLT-2s Fit in the Treatment of Diabetes?

Podcast cover
Read more
Guest: Robert Henry, MD
Host: Steven Edelman, MD

The potential benefits of a new class of medications, sodium-dependent glucose cotransporter-2 therapy (or SGLT-2s), for type 2 diabetes is promising, but where will they fit in the treatment of diabetes and what are the risks? Join host Dr. Steven Edelman and his guest, professor of medicine at the Veterans Affairs Medical Center in San Diego, California, Dr. Robert Henry, as they discuss the mechanism, benefits and potential cardiovascular risks of this new class of medication.

Oct 28 2010

Play

Rank #7: Anti-inflammatory, Anti-atherogenic and Cardioprotective Effects of Insulin

Podcast cover
Read more
Guest: Paresh Dandona, MD, PhD
Host: Farhad Zangeneh, MD

Host Dr. Farhad Zangeneh welcomes Paresh Dandona MD, PhD, Professor and Chief of Endocrinology in the Department of Medicine at the University of Buffalo. His Specialty and Research Focus are in Endocrinology, Diabetes and Metabolism. He is also the Founder & Medical Director of the Diabetes-Endocrinology Center of Western New York. In this program, Dr. Dandona will be discussing insulin induced cardioprotection, inflammatory and oxidative stress in acute myocardial infarction. He will also review hyperglycemia and cardiotoxicity in acute myocardial infarction. Please take a listen!

Jan 28 2013

Play

Rank #8: Psychological Insulin Resistance

Podcast cover
Read more
Guest: Linda Siminerio, RN, PhD, CDE
Host: Steven Edelman, MD

Insulin therapy can be challenging for both the patient with diabetes and their healthcare provider— from needle phobia to weight gain. How can healthcare providers shorten the learning curve to understanding insulin and its benefits? Join host Dr. Steven Edelman and his guest, Dr. Linda Siminerio, associate professor at the University of Pittsburgh School of Medicine, as they discuss insulin fact and fallacy for patients and providers.

May 18 2011

Play

Rank #9: Managing Diabetic Patients with Peripheral Neuropathy

Podcast cover
Read more
Guest: Craig Wargon, DPM
Host: Steven Edelman, MD

Patients with diabetes commonly need treatment for peripheral neuropathy. What are common symptoms and what should a physician be looking for in each patient visit? Join host Dr. Steven Edelman and his guest, practicing physician in the division of podiatric surgery at Kaiser Permanente, Dr. Craig Wargon, as they discuss symptoms, treatment and the need to glycaemic control in patients with diabetes.

Oct 21 2010

Play

Rank #10: Role of the Cardiologist in T2D Management

Podcast cover
Read more
Host: Jennifer Caudle, DO
Guest: Christie Ballantyne, MD

With the number of patients with both type 2 diabetes and established cardiovascular disease on the rise, a personalized patient approach to treating these two conditions is now more important than ever. Joining Dr. Jennifer Caudle to discuss the role of the cardiologist in managing patients with type 2 diabetes is Dr. Christie Ballantyne.

US18VZ00285 January 2019

Feb 26 2019

Play

Rank #11: The Centers for Disease Control’s Approach to Prevention of Diabetes

Podcast cover
Read more
Guest: Ann Albright, PhD, RD
Host: Steven Edelman, MD

The Centers for Disease Control and Prevention is aggressively becoming hands-on in the prevention of type 2 diabetes. A new national diabetes prevention program is under way under the tutelage of previous successful clinical research and trials results. What can healthcare professionals treating patients with diabetes learn and how can they get involved? Join host Dr. Steven Edelman and his guest, the director of the division of diabetes translation at the Centers for Disease Control and Prevention, Dr. Ann Albright, as they discuss the criteria for the National Diabetes Prevention Program.

Oct 05 2010

Play

Rank #12: Healthcare Reform and Implications for the Treatment of Diabetes

Podcast cover
Read more
Guest: Shereen Arent, JD
Host: Steven Edelman, MD

Healthcare reform will have significant implications for both patients living with diabetes and the healthcare professionals treating diabetic patients. How will healthcare reform impact current treatment, access and affordability? Join host Dr. Steven Edelman and his guest, executive vice president of government affairs & advocacy of the American Diabetes Association, Shereen Arent, as they discuss the impact of reform to cost of patient care, current and future prevention programs and the Affordable Care Act.

Oct 28 2010

Play

Rank #13: Care Collaboration: Patients with Type 2 Diabetes & Established Cardiovascular Disease – The Cardiologists' Perspective

Podcast cover
Read more
Host: Jennifer Caudle, DO
Guest: Mikhail Kosiborod, MD
Guest: Christie Ballantyne, MD

Since type 2 diabetes and cardiovascular disease often go hand in hand, having a care collaboration plan in place is essential in managing these conditions. Here to discuss both the challenges and opportunities that arise when collaborating patient care are cardiologists Dr. Mikhail Kosiborod and Dr. Christie Ballantyne.

US18VZ00286 January 2019

Feb 12 2019

Play

Rank #14: Do Incretins Play An Important Role In the Cardiovascular System?

Podcast cover
Read more
Guest: John Buse, MD, PhD
Host: Steven Edelman, MD

Diabetes therapeutics such as glucose and weight control are major physiological functions of the new glucagon-like peptide-1 (GLP-1) agonists. But is there evidence to suggest that GLP-1 may also have some cardiovascular benefits? Join host Dr. Steven Edelman and Dr. John Buse, professor of medicine at the University of North Carolina at Chapel Hill School of Medicine, as they discuss the emerging cardiovascular actions of incretin hormones.

Sep 02 2009

Play

Rank #15: Diabetes Research: Hope for a Cure in Stem Cells?

Podcast cover
Read more
Guest: Emmanuel Baetge, PhD
Host: Steven Edelman, MD

Current stem cell therapy research is leading the way into producing functional pancreatic, insulin-producing cells. How will this translate into clinical trials and human therapy for diabetes from a scale, delivery and efficacy position? Join host Dr. Steven Edelman and his guest Dr. Emmanuel Baetge, chief scientific officer of Viacyte, Inc., as they discuss the benefits of stem cell research therapy for diabetes.

Oct 05 2010

Play

Rank #16: The Diabetes Infrastructure: Regulation & Reimbursement

Podcast cover
Read more
Guest: Kelly Close, MBA
Host: Steven Edelman, MD

The prevalence of diabetes complications and its associated costs represent an infrastructure that may be virtually unsustainable in the near future. Join host Dr. Steven Edelman and his guest, editor-in-chief of the diabetes publications Closer Look and Diabetes Close Up, Kelly Close, as they discuss the challenges of both regulation and reimbursement.

Aug 30 2009

Play

Rank #17: Pediatric Diabetes Research

Podcast cover
Read more
Guest: Alberto Hayek, MD
Host: Steven Edelman, MD

Diabetes research is the cornerstone for new opportunities in the treatment of patients living with diabetes. How will the newly formed Pediatric Diabetes Research Center serve this goal? Join guest host, certified diabetes educator Janice Baker and Dr. Alberto Hayek, professor of pediatrics and co-director of the UC San Diego's Pediatric Diabetes Research Center, as they discuss the need for collaboration in both biochemistry, molecular and cell-based therapies for the treatment of diabetes.

Nov 23 2010

Play

Rank #18: Insulin Pump Practices

Podcast cover
Read more
Guest: John Walsh, PA, CDE
Host: Steven Edelman, MD

Insulin pump practice studies reveal new approaches in the management of diabetes,  including carb-counting, carb boluses, hypoglycemia and transdermal insulin drug delivery. What are actual pump practices that lead to improved control? Join host Dr. Steven Edelman and his guest, John Walsh, PA, and certified diabetes educator at Advanced Metabolic Care and Research in Escondido, California, as they discuss pump practices that lead to improved control.

May 18 2011

Play

Rank #19: Inpatient and Outpatient Recommendations for Diabetes

Podcast cover
Read more
Guest: Jane Seley, DNP, MPH
Host: Steven Edelman, MD

The transition from hospital to home for patients with diabetes can be challenging, from glycemic targets, guidelines for initiating insulin therapy, the various types of insulin and oral agents to general nutrition. What are the current recommendations for the transition from hospital to home for patients living with diabetes? Join host Dr. Steven Edelman and his guest, Dr. Jane Jeffrie Seley, diabetes nurse practitioner and certified diabetes educator at New York-Presbyterian Hospital Weill Cornell Medical Center, as they discuss the differences in the current AACE and ADA inpatient and outpatient recommendations.

May 18 2011

Play

Rank #20: New Developments in Incretins and SGLT Inhibitors

Podcast cover
Read more
Guest: Robert Henry, MD
Host: Steven Edelman, MD

The physiological effects of glucagon-like peptide-1 (GLP-1) are exciting because of the potential clinical relevance in treating two of the major abnormalities that contribute to type 2 diabetes: impaired insulin secretion and excessive glucagon secretion. GLP-1 also appears to have effects on gastric emptying and appetite suppression. Join host Dr. Steven Edelman and his guest Dr. Robert Henry, professor of medicine at the University of California, San Diego, and chief of both the section of endocrinology, metabolism and diabetes and the Center for Metabolic Research at the VA Medical Center in San Diego.

Jun 19 2009

Play